Related Experiment Video
Updated: Apr 6, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice
Objective:
To describe the impact of a pharmacist-run antiarrhythmic clinic in an outpatient practice.
Setting:
Blanchard Valley Medical Associates (BVMA) in Findlay, OH.
Practice Description:
BVMA is a 15-physician private practice with five pharmacists on staff who run several disease management clinics.
Practice Innovation:
Patients receiving amiodarone or sotalol are referred to a pharmacist-run antiarrhythmic clinic within an outpatient physicians' office. The pharmacist is responsible for coordinating, monitoring, and reviewing results with patients.
Evaluation:
A retrospective chart review was conducted to compare adherence to monitoring protocols between patients referred to the pharmacist-run clinic and patients managed solely by physicians, and to evaluate the type and frequency of pharmacist-initiated interventions. Patients had received antiarrhythmic treatment for at least 6 months before the beginning of the retrospective review.
Results:
A total of 130 patient charts were reviewed. Adherence for each recommended testing parameter for patients on amiodarone and sotalol was significantly higher among patients managed by a pharmacist, compared with usual care. A total of 62 adverse events were detected, and 39 interventions were made by the pharmacist group.
Conclusion:
Patients with pharmacist monitoring of outpatient antiarrhythmic medications had greater adherence to recommended testing protocols compared with usual care.
Related Concept Videos
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VII: Nursing Management of Dysrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

